Immuno-Oncology Summit Will Be A Virtual Event For 2020

Like many of you, we have been closely following updates and evolving guidances from local, national and global agencies for COVID-19. There is still much uncertainty around the coronavirus, and how long our communities may be impacted by the pandemic, but it seems certain that decisions about how we work, travel and gather together will continue to be influenced for weeks and months still to come.

We have made the decision not to move forward with an in-person meeting for the Immuno-Oncology Summit this year. Instead, we are hard at work transitioning to a virtual event featuring online sessions, networking, exhibits and posters, running on the original August dates.

600+ IO Thought
100+ Scientific
5 Days of
30% Executive-Level

Featured Speakers

Roy Baynes
Senior VP and Head, Global Clinical Development, CMO, Merck

Marcus Bosenberg
Interim Director, Yale Center for Immuno-Oncology, Yale Univ.

Zhao Chen
Lab Head, Exploratory Immuno-Oncology, Novartis

Raphael Clynes
VP, Translational Biology, Xencor

Virna Cortez-Retamozo
Lab Head, Oncology-Pharmacology, Sanofi

Adil Daud
Director, Melanoma Clinical Research, UCSF Helen Diller Family Comprehensive Cancer Center

Matthias Gromeier
Professor, Neurosurgery, Duke Cancer Institute

Cara Haymaker
Director, Oncology Research and Immuno-Monitoring Core (ORION), Univ. of Texas MD Anderson Cancer Center

Keith Knutson
Director, Immunology & Immunotherapy, Mayo Clinic

Ravi Madan
Clinical Director, Genitourinary Malignancies Branch, NCI NIH

Robert Pierce
Scientific Director, Immunopathology Core, Fred Hutchinson Cancer Research Center

David A. Reardon
Clinical Director, Center for Neuro-Oncology, Dana-Farber Cancer Institute

Shahram Salek-Ardakani
Director, Cancer Immunology, Pfizer

Andrew Weinberg
Chief, Laboratory of Basic Immunology, Providence Health & Services

Theresa Whiteside
Professor, Pathology, Immunology, Univ. of Pittsburgh School of Medicine

About the Immuno-Oncology Summit

Over the past 8 years, CHI's Immuno-Oncology Summit has become the leading annual meeting focusing on the latest applied research, providing comprehensive and in-depth coverage across all modalities and stages in the pipeline. Every year, we assemble an international mix of thought leaders and decision makers from industry and academia to bring you the latest developments in immuno-oncology, while providing access to a comprehensive 5-day program and extensive networking opportunities that CHI's IO Summit provides.

Connect With Us


For meeting questions or suggestions, please contact:

Julia Boguslavsky
Executive Director, Conferences
Cambridge Healthtech Institute


For partnering and sponsorship info, please contact:

Rod Eymael
Manager, Business Development
Cambridge Healthtech Institute
+1 781.247.6286


For media and association partnerships, please contact:

Pete DeOlympio
Sr. Marketing Manager
Cambridge Healthtech Institute
+1 781.972.5415